Michael J Haller

Summary

Affiliation: University of Florida
Country: USA

Publications

  1. ncbi Predictors of control of diabetes: monitoring may be the key
    Michael J Haller
    Division of Pediatric Endocrinology, Department of Pediatrics, University of Florida, Gainesville, Florida 32610, USA
    J Pediatr 144:660-1. 2004
  2. ncbi Adverse impact of temperature and humidity on blood glucose monitoring reliability: a pilot study
    Michael J Haller
    Division of Pediatric Endocrinology, University of Florida, Gainesville, Florida 32610, USA
    Diabetes Technol Ther 9:1-9. 2007
  3. ncbi Peripheral artery tonometry demonstrates altered endothelial function in children with type 1 diabetes
    Michael J Haller
    Division of Pediatric Endocrinology, Department of Pediatrics, University of Florida, Gainesville, FL, USA
    Pediatr Diabetes 8:193-8. 2007
  4. ncbi Neonatal diabetes mellitus and congenital diaphragmatic hernia: coincidence or concurrent etiology?
    Emmanuelle S Topiol
    University of Florida, Department of Pediatrics, Division of Endocrinology, PO Box 100296, Gainesville, FL, 32610, USA
    Int J Pediatr Endocrinol 2012:21. 2012
  5. ncbi Efforts to prevent and halt autoimmune beta cell destruction
    Michael J Haller
    Division of Endocrinology, Department of Pediatrics, University of Florida, PO Box 100296, Gainesville, FL 32610, USA
    Endocrinol Metab Clin North Am 39:527-39. 2010
  6. ncbi Autologous umbilical cord blood transfusion in very young children with type 1 diabetes
    Michael J Haller
    Department of Pediatrics, The University of Florida, Gainesville, Florida, USA
    Diabetes Care 32:2041-6. 2009
  7. ncbi The road not taken: a path to curing type 1 diabetes?
    Michael J Haller
    Department of Pediatrics, University of Florida, Gainesville, FL 32610, USA
    Eur J Immunol 39:2054-8. 2009
  8. ncbi Pediatric Atorvastatin in Diabetes Trial (PADIT): a pilot study to determine the effect of atorvastatin on arterial stiffness and endothelial function in children with type 1 diabetes mellitus
    Michael J Haller
    Division of Pediatric Endocrinology, Department of Pediatrics, University of Florida, Gainesville, FL 32610, USA
    J Pediatr Endocrinol Metab 22:65-8. 2009
  9. ncbi Autologous umbilical cord blood infusion for type 1 diabetes
    Michael J Haller
    Department of Pediatrics, University of Florida, Gainesville, FL 32610, USA
    Exp Hematol 36:710-5. 2008
  10. ncbi Type 1 diabetes intervention trials 2007: where are we and where are we going?
    Michael J Haller
    Department of Pediatrics, University of Florida, Gainesville, Florida 32610, USA
    Curr Opin Endocrinol Diabetes Obes 14:283-7. 2007

Collaborators

Detail Information

Publications35

  1. ncbi Predictors of control of diabetes: monitoring may be the key
    Michael J Haller
    Division of Pediatric Endocrinology, Department of Pediatrics, University of Florida, Gainesville, Florida 32610, USA
    J Pediatr 144:660-1. 2004
    ..Frequent self-monitoring of blood glucose promotes long-term metabolic control...
  2. ncbi Adverse impact of temperature and humidity on blood glucose monitoring reliability: a pilot study
    Michael J Haller
    Division of Pediatric Endocrinology, University of Florida, Gainesville, Florida 32610, USA
    Diabetes Technol Ther 9:1-9. 2007
    ..We performed a study to determine if the effect of temperature and humidity on glucose values could be accurately predicted...
  3. ncbi Peripheral artery tonometry demonstrates altered endothelial function in children with type 1 diabetes
    Michael J Haller
    Division of Pediatric Endocrinology, Department of Pediatrics, University of Florida, Gainesville, FL, USA
    Pediatr Diabetes 8:193-8. 2007
    ..To assess the ability of reactive hyperemia-peripheral artery tonometry (RH-PAT) to serve as a surrogate marker of endothelial dysfunction in children with type 1 diabetes (T1D)...
  4. ncbi Neonatal diabetes mellitus and congenital diaphragmatic hernia: coincidence or concurrent etiology?
    Emmanuelle S Topiol
    University of Florida, Department of Pediatrics, Division of Endocrinology, PO Box 100296, Gainesville, FL, 32610, USA
    Int J Pediatr Endocrinol 2012:21. 2012
    ..In addition to reviewing the management and genetics of NDM we discuss the potential for overlapping genetic or embryologic abnormalities to explain the concurrence of CDH and NDM...
  5. ncbi Efforts to prevent and halt autoimmune beta cell destruction
    Michael J Haller
    Division of Endocrinology, Department of Pediatrics, University of Florida, PO Box 100296, Gainesville, FL 32610, USA
    Endocrinol Metab Clin North Am 39:527-39. 2010
    ....
  6. ncbi Autologous umbilical cord blood transfusion in very young children with type 1 diabetes
    Michael J Haller
    Department of Pediatrics, The University of Florida, Gainesville, Florida, USA
    Diabetes Care 32:2041-6. 2009
    ..We conducted an open-label phase I study using autologous umbilical cord blood infusion to ameliorate type 1 diabetes...
  7. ncbi The road not taken: a path to curing type 1 diabetes?
    Michael J Haller
    Department of Pediatrics, University of Florida, Gainesville, FL 32610, USA
    Eur J Immunol 39:2054-8. 2009
    ....
  8. ncbi Pediatric Atorvastatin in Diabetes Trial (PADIT): a pilot study to determine the effect of atorvastatin on arterial stiffness and endothelial function in children with type 1 diabetes mellitus
    Michael J Haller
    Division of Pediatric Endocrinology, Department of Pediatrics, University of Florida, Gainesville, FL 32610, USA
    J Pediatr Endocrinol Metab 22:65-8. 2009
    ..Secondary analysis demonstrated potential reduction of arterial stiffness following atorvastatin therapy (p = 0.06). Additional long-term prospective studies with larger numbers of patients are needed...
  9. ncbi Autologous umbilical cord blood infusion for type 1 diabetes
    Michael J Haller
    Department of Pediatrics, University of Florida, Gainesville, FL 32610, USA
    Exp Hematol 36:710-5. 2008
    ..Herein, we describe the scientific and therapeutic rationale underlying efforts utilizing umbilical cord blood (UCB) as a therapy for ameliorating the progression of this autoimmune disease...
  10. ncbi Type 1 diabetes intervention trials 2007: where are we and where are we going?
    Michael J Haller
    Department of Pediatrics, University of Florida, Gainesville, Florida 32610, USA
    Curr Opin Endocrinol Diabetes Obes 14:283-7. 2007
    ..This review explores the lessons learned from recent type 1 diabetes interventional studies, sets out controversial issues and seeks to provide a roadmap for future interventions...
  11. ncbi Endocrine complications of childhood cancer therapy: evaluation and management
    Michael J Haller
    Department of Pediatrics, University of Florida School of Medicine, Gainesville, FL 32610, USA
    Pediatr Endocrinol Rev 4:196-204. 2007
    ..The following review will identify endocrinopathies associated with different chemotherapy and radiation protocols and will review lifelong screening and treatment strategies for endocrine complications of childhood cancer...
  12. ncbi Autologous umbilical cord blood transfusion in young children with type 1 diabetes fails to preserve C-peptide
    Michael J Haller
    Department of Pediatrics, University of Florida, Gainesville, Florida, USA
    Diabetes Care 34:2567-9. 2011
    ..Having previously reported on the first 15 patients reaching 1 year of follow-up, herein we report on the complete cohort after 2 years of follow-up...
  13. ncbi Serum superoxide dismutase activity and nitric oxide do not correlate with arterial stiffness in children with type 1 diabetes mellitus
    Michael J Haller
    Division of Pediatric Endocrinology, Department of Pediatrics University of Florida, Gainesville 32610, USA
    J Pediatr Endocrinol Metab 19:267-9. 2006
  14. ncbi Arterial thrombosis resulting in amputation in a child with poorly controlled type 1 diabetes and heterozygous Factor V Leiden mutation
    Michael J Haller
    Division of Pediatric Endocrinology, Department of Pediatrics, University of Florida, Gainesville, FL, USA
    Pediatr Diabetes 7:229-31. 2006
    ..This report emphasizes the need to test for thrombophilic defects in children with thrombosis or with a family history of thrombosis. Good metabolic control is especially important in children with T1DM and known thrombophilic defects...
  15. ncbi Radial artery tonometry demonstrates arterial stiffness in children with type 1 diabetes
    Michael J Haller
    Pediatric Endocrinology, P O Box 100296, Gainesville, FL 32610, USA
    Diabetes Care 27:2911-7. 2004
    ..To determine if children with type 1 diabetes have increased arterial stiffness by estimating augmentation index with the simple noninvasive technique of radial artery tonometry...
  16. ncbi Exendin-4 treatment of nonobese diabetic mice increases beta-cell proliferation and fractional insulin reactive area
    Song Xue
    Department of Pathology, University of Florida, Gainesville, FL 32610, USA
    J Diabetes Complications 24:163-7. 2010
    ....
  17. ncbi Progressive erosion of β-cell function precedes the onset of hyperglycemia in the NOD mouse model of type 1 diabetes
    Diego Ize-Ludlow
    Department of Pediatrics, Division of Pediatric Endocrinology, Diabetes and Metabolism, Children s Hospital of Pittsburgh of University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
    Diabetes 60:2086-91. 2011
    ..A progressive decline in insulin responses to glucose was noted in individuals before the onset of type 1 diabetes. We determined whether such abnormalities occurred in prediabetic NOD mice-the prototypic model for human type 1 diabetes...
  18. ncbi Development of autoantibodies in the TrialNet Natural History Study
    Kendra Vehik
    University of South Florida, Pediatrics Epidemiology Center, Tampa, FL, USA
    Diabetes Care 34:1897-901. 2011
    ....
  19. ncbi Type 1 diabetes: current concepts in epidemiology, pathophysiology, clinical care, and research
    Mary Joyce Gan
    Department of Pediatrics, University of Florida, Gainesville, FL, USA
    Curr Probl Pediatr Adolesc Health Care 42:269-91. 2012
    ..Herein, we provide a comprehensive review of the natural history, pathophysiology, and contemporary management of T1D. In addition, recent advances in T1D research are discussed...
  20. ncbi Exendin-4 therapy in NOD mice with new-onset diabetes increases regulatory T cell frequency
    Song Xue
    Department of Pathology, University of Florida, Florida 32010, USA
    Ann N Y Acad Sci 1150:152-6. 2008
    ..Taken collectively, these data suggest that in addition to its potential effects on beta cell proliferation, Ex-4 may also act as a regulator of the immune response...
  21. ncbi Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice
    Matthew J Parker
    Department of Pathology, University of Florida, Gainesville, Florida, USA
    Diabetes 58:2277-84. 2009
    ....
  22. ncbi Type 1 diabetes mellitus: etiology, presentation, and management
    Michael J Haller
    Division of Pediatric Endocrinology, University of Florida College of Medicine, PO Box 100296, Gainesville, FL 32610, USA
    Pediatr Clin North Am 52:1553-78. 2005
    ..Finally, the article discusses the future of diabetes screening programs and the progress toward the ultimate goal of curing type 1 diabetes...
  23. ncbi Vascular dysfunction in glycogen storage disease type I
    Angelina V Bernier
    Division of Pediatric Endocrinology and Glycogen Storage Disease Program, Department of Pediatrics, University of Florida, Gainesville, FL 32610 0296, USA
    J Pediatr 154:588-91. 2009
    ..To determine cardiovascular disease risk in a larger cohort of patients with glycogen storage disease (GSD) I through the use of noninvasive measures of arterial function and anatomy...
  24. ncbi Serum monocyte chemoattractant protein-1 concentrations associate with diabetes status but not arterial stiffness in children with type 1 diabetes
    Issam Zineh
    Department of Pharmacy Practice and Center for Pharmacogenomics, University of Florida College of Pharmacy, Gainesville, Florida, USA
    Diabetes Care 32:465-7. 2009
    ..We tested whether inflammatory monocyte chemoattractant protein (MCP)-1 concentrations correlate with arterial stiffness or type 1 diabetes status...
  25. ncbi Assessing the in vitro suppressive capacity of regulatory T cells
    Todd M Brusko
    Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida, USA
    Immunol Invest 36:607-28. 2007
    ..As further immunomodulatory therapies are explored, the need for additional methodologies to understand the cellular and molecular mechanisms of immune regulation conferred by Treg will play an increasingly important role...
  26. ncbi Arterial stiffness, lipoprotein particle size, and lipoprotein particle concentration in children with type 1 diabetes
    Lisa M Gallo
    Division of Pediatric Endocrinology, Department of Pediatrics, University of Florida, Gainesville, Florida, USA
    J Pediatr Endocrinol Metab 23:661-7. 2010
    ..To determine if lipoprotein particle abnormalities correlate with arterial stiffness in children with type 1 diabetes (T1D)...
  27. ncbi Diabetic ketoacidosis at diabetes onset: still an all too common threat in youth
    Georgeanna J Klingensmith
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, CO, USA
    J Pediatr 162:330-4.e1. 2013
    ..To define the demographic and clinical characteristics of children at the onset of type 1 diabetes (T1D), with particular attention to the frequency of diabetic ketoacidosis (DKA)...
  28. ncbi NOS3 polymorphisms are associated with arterial stiffness in children with type 1 diabetes
    Issam Zineh
    Department of Pharmacy Practice and Center for Pharmacogenomics, University of Florida College of Pharmacy, Gainesville, Florida, USA
    Diabetes Care 30:689-93. 2007
    ..We hypothesized that polymorphisms in the NOS3 gene may be associated with the differences seen in arterial stiffness within the population of children with type 1 diabetes...
  29. ncbi Islet autoantibody seroconversion in the DPT-1 study: justification for repeat screening throughout childhood
    Kendra Vehik
    Pediatrics Epidemiology Center, University of South Florida, Tampa, Florida, USA
    Diabetes Care 34:358-62. 2011
    ..Our aim was to determine the timing of seroconversion to diabetes-associated autoantibody (DAA) positivity and risk in first- and second-degree relatives of patients with type 1 diabetes...
  30. ncbi Update on global intervention studies in type 1 diabetes
    Jane L Chiang
    Division of Endocrinology, Department of Pediatrics, Stanford University, 300 Pasteur Drive, G 313, Stanford, CA 94305, USA Electronic address
    Endocrinol Metab Clin North Am 41:695-712. 2012
    ..This article updates the principles used to design prevention and intervention trials, reviews clinical trials, addresses controversial issues, and provides a framework for future efforts to interdict this condition...
  31. ncbi Tanner stage 4 breast development in adults: forensic implications
    Arlan L Rosenbloom
    Division of Endocrinology, Department of Pediatrics, University of Florida College of Medicine, 1701 SW 16th Ave, PO Box 100296, Gainesville, FL 32608, USA
    Pediatrics 130:e978-81. 2012
    ..Clinical experience does not support this notion, but there are no relevant studies. We sought to estimate how frequently TS 4 might be interpreted from nonclinical images by individual forensic experts...
  32. ncbi Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapy
    Jean Y Park
    Clinical Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Clin Endocrinol Metab 93:26-31. 2008
    ..Acquired generalized lipodystrophy (AGL) is marked by severe insulin resistance and hypertriglyceridemia. Rarely, AGL and type 1 diabetes (T1D) coexist...
  33. ncbi Correlation between radial artery tonometry- and fingertip tonometry-derived augmentation index in children with type 1 diabetes
    Michael J Haller
    Diab Vasc Dis Res 4:66. 2007
  34. ncbi Cytokines and type 1 diabetes complications: casual or causal association?
    Michael J Haller
    Pediatr Diabetes 9:1-2. 2008
  35. ncbi CD3-antibody therapy in new-onset type 1 diabetes mellitus
    Michael J Haller
    N Engl J Med 353:2086-7; author reply 2086-7. 2005